Pregled bibliografske jedinice broj: 1135189
GLI transcription targets in melanoma cell lines
GLI transcription targets in melanoma cell lines // 45th FEBS Virtual Congress “Molecules of Life: Towards New Horizons“
online, 2021. (poster, recenziran, neobjavljeni rad, znanstveni)
CROSBI ID: 1135189 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
GLI transcription targets in melanoma cell lines
Autori
Rinčić, Nikolina ; Nenad, Bartoniček ; Matea, Kurtović ; Vesna, Musani ; Diana, Trnski ; Petar, Ozretić ; Maja, Sabol
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, neobjavljeni rad, znanstveni
Skup
45th FEBS Virtual Congress “Molecules of Life: Towards New Horizons“
Mjesto i datum
Online, 03.07.2021. - 08.07.2021
Vrsta sudjelovanja
Poster
Vrsta recenzije
Recenziran
Ključne riječi
melanom ; proteini GLI ; ChIP-seq ; BRAF ; NRAS
Sažetak
HedgehogGLI signaling pathway is one of the key regulators of normal development. Its aberrant signaling activity has been implicated in the initiation, progression and relapse of various types of cancer, including melanoma. Previous studies in our laboratory demonstrated that BRAF and NRAS melanomas have different response to HH GLI signaling pathway inhibition. Identifying GLI protein functions in melanoma cell lines with different mutational background represents a distinct potential for the development of combined therapy with HHGLI signaling pathway and BRAF/NRAS inhibitors. For that purpose, chromatin immunoprecipitation sequencing (ChIPseq) was performed. The mutational status of 14 collected melanoma cell lines was confirmed by Sanger sequencing and the cell lines were divided into three categories based on their mutational background: BRAFmutated, NRASmutated, and wild type for BRAF and NRAS. Three cell lines were selected for ChIP analysis based on protein expression of HHGLI signaling pathway components: CHL1 for the wildtype cell group, A375 for the cell group with BRAF gene mutation and MEL224 for the cell group with NRAS gene mutation. Purified chromatin samples were used for library preparation and proceeded for nextgeneration sequencing (NGS). Target genes were analyzed in silico and validated by quantitative polymerase chain reaction (qPCR). qPCR validation included selected 23 protein coding genes, 9 miRNAs and 3 lncRNAs involved in regulation of MAPK signaling pathway. Further analysis can bring new insights into HHGLI and MAPK signaling interplay and development of combined therapy.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Projekti:
HRZZ-IP-2018-01-4889 - Regulacija GLI koda u tumorima ovisnim o BRAF/NRAS mutacijama (GLIcode) (Sabol, Maja, HRZZ - 2018-01) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Matea Kurtović
(autor)
Petar Ozretić
(autor)
Vesna Musani
(autor)
Nikolina Piteša
(autor)
Maja Sabol
(autor)
Diana Trnski
(autor)